United States - English - NLM (National Library of Medicine)

atlantic biologicals corp. - promethazine hydrochloride (unii: r61zeh7i1i) (promethazine - unii:ff28ejq494) - promethazine hydrochloride 6.25 mg in 5 ml - promethazine is useful for: perennial and seasonal allergic rhinitis. vasomotor rhinitis. allergic conjunctivitis due to inhalant allergens and foods. mild, uncomplicated allergic skin manifestations of urticaria and angioedema. amelioration of allergic reactions to blood or plasma. dermographism. anaphylactic reactions, as adjunctive therapy to epinephrine and other standard measures, after the acute manifestations have been controlled. preoperative, postoperative, or obstetric sedation. prevention and control of nausea and vomiting associated with certain types of anesthesia and surgery. therapy adjunctive to meperidine or other analgesics for control of post-operative pain. sedation in both children and adults, as well as relief of apprehension and production of light sleep from which the patient can be easily aroused. active and prophylactic treatment of motion sickness. antiemetic therapy in postoperative patients. promethazine syrup is contraindicated for use in pediatric patients less than two years of

United States - English - NLM (National Library of Medicine)

meridian medical technologies, inc. - pralidoxime chloride (unii: 38x7xs076h) (pralidoxime - unii:p7mu9utp52) - pralidoxime chloride 600 mg in 2 ml - this auto-injector for pralidoxime chloride is specifically indicated for intramuscular use as an adjunct to atropine in the treatment of poisoning by nerve agents having anticholinesterase activity. the pralidoxime chloride auto-injector is contraindicated in patients who are hypersensitive to any component of the product. pralidoxime chloride is not subject to abuse and possesses no known potential for dependence.

United States - English - NLM (National Library of Medicine)

carilion materials management - ondansetron hydrochloride (unii: nmh84ozk2b) (ondansetron - unii:4af302esos) - ondansetron 4 mg in 5 ml - the concomitant use of apomorphine with ondansetron oral solution, usp is contraindicated based on reports of profound hypotension and loss of consciousness when apomorphine was administered with ondansetron oral solution, usp. ondansetron oral solution, usp is contraindicated for patients known to have hypersensitivity to the drug. animal studies have shown that ondansetron is not discriminated as a benzodiazepine nor does it substitute for benzodiazepines in direct addiction studies.

United States - English - NLM (National Library of Medicine)

atlantic biologicals corp. - dextromethorphan hydrobromide (unii: 9d2rti9kyh) (dextromethorphan - unii:7355x3rots), promethazine hydrochloride (unii: r61zeh7i1i) (promethazine - unii:ff28ejq494) - dextromethorphan hydrobromide 15 mg in 5 ml - promethazine hydrochloride and dextromethorphan hydrobromide syrup is indicated for the temporary relief of coughs and upper respiratory symptoms associated with allergy or the common cold. dextromethorphan should not be used in patients receiving a monoamine oxidase inhibitor (maoi) (see ). precautions, drug interactions promethazine is contraindicated in comatose states, and in individuals known to be hypersensitive or to have had an idiosyncratic reaction to promethazine or to other phenothiazines. antihistamines are contraindicated for use in the treatment of lower respiratory tract symptoms, including asthma. according to the who expert committee on drug dependence, dextromethorphan could produce very slight psychic dependence but no physical dependence.

United States - English - NLM (National Library of Medicine)

atlantic biologicals corp. - midazolam hydrochloride (unii: w7ttw573jj) (midazolam - unii:r60l0sm5bc) - midazolam 2 mg in 1 ml - midazolam hcl syrup is indicated for use in pediatric patients for sedation, anxiolysis and amnesia prior to diagnostic, therapeutic or endoscopic procedures or before induction of anesthesia. midazolam hcl syrup is intended for use in monitored settings only and not for chronic or home use (see ). warningsmidazolam hcl syrup must be used as specified in the label. midazolam is associated with a high incidence of partial or complete impairment of recall for the next several hours (see ). clinical pharmacology midazolam is contraindicated in patients with a known hypersensitivity to the drug or allergies to cherries or formulation excipients. benzodiazepines are contraindicated in patients with acute narrow-angle glaucoma. benzodiazepines may be used in patients with open-angle glaucoma only if they are receiving appropriate therapy. measurements of intraocular pressure in patients without eye disease show a moderate lowering following induction of genera

United States - English - NLM (National Library of Medicine)

lake erie medical dba quality care products llc - topiramate (unii: 0h73wjj391) (topiramate - unii:0h73wjj391) - topiramate 50 mg - topiramate tablets usp are indicated as initial monotherapy in patients 2 years of age and older with partial onset or primary generalized tonic-clonic seizures. safety and effectiveness in patients who were converted to monotherapy from a previous regimen of other anticonvulsant drugs have not been established in controlled trials [see clinical studies (14.1)] . topiramate tablets usp are indicated as adjunctive therapy for adults and pediatric patients ages 2 to 16 years with partial onset seizures or primary generalized tonic-clonic seizures, and in patients 2 years of age and older with seizures associated with lennox-gastaut syndrome [see clinical studies (14.2)] . none pregnancy category d [see warnings and precautions 5.7 ] topiramate tablets can cause fetal harm when administered to a pregnant woman. data from pregnancy registries indicate that infants exposed to topiramate in utero have an increased risk for cleft lip and/or cleft palate (oral clefts). when multiple species of pregnant animals rec

United States - English - NLM (National Library of Medicine)

carilion materials management - propranolol hydrochloride (unii: f8a3652h1v) (propranolol - unii:9y8nxq24vq) - propranolol hydrochloride 20 mg in 5 ml - propranolol hydrochloride oral solution is indicated in the management of hypertension. it may be used alone or used in combination with other antihypertensive agents, particularly a thiazide diuretic. propranolol is not indicated in the management of hypertensive emergencies. propranolol hydrochloride oral solution is indicated to decrease angina frequency and increase exercise tolerance in patients with angina pectoris. propranolol hydrochloride oral solution is indicated to control ventricular rate in patients with atrial fibrillation and a rapid ventricular response. propranolol hydrochloride oral solution is indicated to reduce cardiovascular mortality in patients who have survived the acute phase of myocardial infarction and are clinically stable. propranolol hydrochloride oral solution is indicated for the prophylaxis of common migraine headache. the efficacy of propranolol in the treatment of a migraine attack that has started has not been established, and propranolol is not indicated for such use. pr

United States - English - NLM (National Library of Medicine)

atlantic biologicals corps - promethazine hydrochloride (unii: r61zeh7i1i) (promethazine - unii:ff28ejq494), codeine phosphate (unii: gsl05y1mn6) (codeine anhydrous - unii:ux6owy2v7j) - promethazine hydrochloride 6.25 mg in 5 ml - promethazine hydrochloride and codeine phosphate syrup is indicated for the temporary relief of coughs and upper respiratory symptoms associated with allergy or the common cold. the combination of promethazine hydrochloride and codeine phosphate is contraindicated in pediatric patients less than 6 years of age, because the combination may cause fatal respiratory depression in this age population. codeine is contraindicated in patients with a known hypersensitivity to the drug. promethazine is contraindicated in comatose states, and in individuals known to be hypersensitive or to have had an idiosyncratic reaction to promethazine or to other phenothiazines. antihistamines and codeine are both contraindicated for use in the treatment of lower respiratory tract symptoms, including asthma. promethazine hydrochloride and codeine phosphate syrup is a schedule v controlled substance. codeine is known to be subject to abuse; however, the abuse potential of oral codeine appears to be quite low. even parenteral codeine

United States - English - NLM (National Library of Medicine)

atlantic biologicals corps - hydrocodone bitartrate (unii: no70w886kk) (hydrocodone - unii:6yks4y3wq7), acetaminophen (unii: 362o9itl9d) (acetaminophen - unii:362o9itl9d) - hydrocodone bitartrate 10 mg in 15 ml - lortab elixir is indicated for the relief of moderate to moderately severe pain. this product should not be administered to patients who have previously exhibited hypersensitivity to hydrocodone, acetaminophen, or any other component of this product. patients known to be hypersensitive to other opioids may exhibit cross-sensitivity to hydrocodone. lortab elixir contains hydrocodone, an opioid agonist, and is a schedule ii controlled substance. lortab elixir, and other opioids used in analgesia can be abused and are subject to criminal diversion. addiction is a primary, chronic, neurobiologic disease, with genetic psychosocial, and environmental factors influencing its development and manifestations. it is characterized by behaviors that include one or more of the following: impaired control over drug use, compulsive use, continued use despite harm, and craving. drug addiction is a treatable disease utilizing a multidisciplinary approach, but relapse is common. “drug seeking” behavior is very common in addicts

United States - English - NLM (National Library of Medicine)

baxter healthcare corporation - pralidoxime chloride (unii: 38x7xs076h) (pralidoxime - unii:p7mu9utp52) - pralidoxime chloride 1 g in 20 ml - protopam chloride is indicated as an antidote: the principal indications for the use of protopam chloride are muscle weakness and respiratory depression. in severe poisoning, respiratory depression may be due to muscle weakness. there are no known absolute contraindications for the use of protopam chloride (see precautions, drug interactions and dosage and administration). relative contraindications include known hypersensitivity to the drug and other situations in which the risk of its use clearly outweighs possible benefit. protopam chloride is not subject to abuse and possesses no known potential for dependence.